Table 1. Mean ± S.D of all the measured parameters in brain homogenate of PPA treated male and female mice groups compared to control group. Only P values ≤0.05 were considered significant.
| Parameters | Groups | N | Min. | Max. | Mean ± S.D. | P value a | P value b | |
|---|---|---|---|---|---|---|---|---|
| IL- 6 (pg/ml) | Control Male | 10 | 34.25 | 45.13 | 38.90 ± 3.41 | 0.786 | 0.688 | |
| PPA Treated Male | 6 | 21.27 | 86.11 | 42.99 ± 22.36 | ||||
| Control Female | 9 | 20.21 | 43.03 | 34.50 ± 6.98 | 0.084 | |||
| PPA Treated Female | 6 | 30.49 | 48.76 | 41.29 ± 6.74 | ||||
| IL-10 (pg/ml) | Control Male | 10 | 2121.20 | 2712.10 | 2395.60 ± 140.33 | 0.017 | 0.593 | |
| PPA Treated Male | 6 | 2318.20 | 3444.40 | 2939.40 ± 361.78 | ||||
| Control Female | 9 | 2186.90 | 2409.10 | 2287.90 ± 56.23 | 0.001 | |||
| PPA Treated Female | 6 | 2399.00 | 3368.80 | 2831.70 ± 311.96 | ||||
| Glu (nmol/ml) | Control Male | 10 | 17.68 | 22.00 | 20.09 ± 1.33 | 0.046 | 0.001 | |
| PPA Treated Male | 6 | 11.24 | 19.81 | 16.70 ± 3.15 | ||||
| Control Female | 9 | 13.14 | 18.88 | 16.30 ± 1.93 | 0.001 | |||
| PPA Treated Female | 6 | 22.37 | 26.13 | 23.87 ± 1.71 | ||||
| GABA (pg/ml) | Control Male | 10 | 33.43 | 48.78 | 42.59 ± 4.30 | 0.026 | 0.123 | |
| PPA Treated Male | 6 | 43.63 | 52.77 | 47.62 ± 3.11 | ||||
| Control Female | 9 | 45.34 | 48.50 | 46.95 ± 0.82 | 0.001 | |||
| PPA Treated Female | 6 | 48.62 | 51.41 | 49.84 ± 0.90 | ||||
| LDH (U/ml) | Control Male | 10 | 720.73 | 1182.17 | 1020.42 ± 126.37 | 0.021 | 0.094 | |
| PPA Treated Male | 6 | 522.97 | 1010.77 | 751.12 ± 204.27 | ||||
| Control Female | 9 | 637.23 | 1164.59 | 852.58 ± 136.27 | 0.246 | |||
| PPA Treated Female | 6 | 652.61 | 1241.49 | 987.34 ± 236.88 | ||||
| CK (IU/ml) | Control Male | 10 | 582.29 | 1357.95 | 968.29 ± 261.51 | 0.660 | 0.337 | |
| PPA Treated Male | 6 | 430.68 | 2190.74 | 1063.88 ± 593.49 | ||||
| Control Female | 9 | 465.83 | 1786.43 | 1027.49 ± 453.95 | 0.321 | |||
| PPA Treated Female | 6 | 509.78 | 1292.03 | 811.55 ± 283.89 | ||||
| GSH (µg/ml) | Control Male | 10 | 9.49 | 12.34 | 11.19 ± 0.88 | 0.307 | 0.873 | |
| PPA Treated Male | 6 | 6.01 | 14.24 | 9.81 ± 2.93 | ||||
| Control Female | 9 | 7.91 | 14.24 | 10.64 ± 1.92 | 0.954 | |||
| PPA Treated Female | 6 | 6.96 | 17.72 | 10.55 ± 4.11 | ||||
| GST (U/ml) | Control Male | 10 | 0.23 | 0.37 | 0.31 ± 0.04 | 0.060 | 0.234 | |
| PPA Treated Male | 6 | 0.21 | 0.33 | 0.26 ± 0.04 | ||||
| Control Female | 9 | 0.21 | 0.37 | 0.28 ± 0.06 | 0.545 | |||
| PPA Treated Female | 6 | 0.23 | 0.39 | 0.30 ± 0.05 | ||||
| Catalase (U/ml) | Control Male | 10 | 0.00 | 0.01 | 0.007 ± 0.002 | 0.012 | 0.225 | |
| PPA Treated Male | 6 | 0.01 | 0.02 | 0.012 ± 0.005 | ||||
| Control Female | 9 | 0.00 | 0.01 | 0.008 ± 0.003 | 0.205 | |||
| PPA Treated Female | 6 | 0.01 | 0.01 | 0.010 ± 0.001 | ||||
Notes.
P value between control and corresponding PPA traded group.
P value between PPA treated groups.